Phenomix Sciences uses precision medicine platform to predict obesity treatment outcomes

Phenomix Sciences has launched their Phenomix Sciences Obesity Platform, a set of data and tools that personalize obesity treatments.“The Platform was developed with a goal to combat obesity with data-driven medicine,” Mark Bagnall, CEO of Phenomix, told Healio. “Obesity isn’t one disease, but many, and at least four can be determined by phenotyping. In fact, the four phenotype categories account for 90% of obese patients. Phenomix is the first to bring a solution to market based on the science of phenotyping.”The Phenomix Sciences Obesity Platform uses data fromRead More